Today: 30 June 2026
Applied Materials stock jumps as Wall Street lifts targets — what AMAT traders watch next
2 February 2026
1 min read

Applied Materials stock jumps as Wall Street lifts targets — what AMAT traders watch next

New York, February 2, 2026, 11:46 EST — Trading during the regular session.

  • Shares of Applied Materials climbed roughly 2% in morning trading following new target price increases
  • Morgan Stanley raised its target to $364, while UBS pushed its target up to $405
  • Feb. 12 earnings will be the next crucial checkpoint for demand and forward-looking guidance

Applied Materials shares climbed roughly 2% Monday, building on an early rally as brokerages raised price targets ahead of next week’s earnings from the chip equipment maker. The stock last changed hands at $328.95, up $6.63, within a range of $314.00 to $330.26.

This matters now since Applied is a bellwether for wafer fab equipment (WFE) — those pricey machines chipmakers use to ramp up capacity. When the calendar’s tight, even a slight change in outlook can hit the stock fast.

Earnings season is approaching, and the market is weighing if demand is picking up or merely taking a breather. For firms linked to capex cycles, hitting “good enough” often falls short.

Morgan Stanley’s Shane Brett bumped up his price target for Applied Materials to $364 from $273, maintaining an “Overweight” rating, Benzinga reported. Benzinga

UBS raised its target price to $405 from $285 and kept its “Buy” rating, according to an MT Newswires report featured on MarketScreener. MarketScreener

A Morgan Stanley note flagged this as a likely “beat and raise” quarter, citing better demand and easing supply-chain issues, MarketScreener reported. MarketScreener

Applied Materials provides deposition, etch, and other equipment essential for making logic and memory chips, along with services that help steady earnings when customers cut back on new tool purchases. Its rivals include Lam Research and KLA in several segments of the chip-tool industry.

Still, the China situation looms large. Applied warned that stricter U.S. export rules will cut its China equipment sales in fiscal 2026, flagging a $600 million hit in revenue tied to the wider restrictions.

The company will release its fiscal first-quarter results on Feb. 12 and plans to hold a conference call at 4:30 p.m. ET, it announced.

Investors are eyeing any shift in management’s outlook on demand for the second half of 2026, along with the balance between memory spending and cutting-edge foundry projects driving the next growth phase. The next key date to watch is Feb. 12.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Stock Market Today

  • Wells Fargo Lifts AMD (AMD) Target to $615 on Server CPU Demand, Keeps Overweight
    June 30, 2026, 5:04 PM EDT. Wells Fargo moved its price target on Advanced Micro Devices (AMD) up to $615, from $505, and held its Overweight rating. The bank pointed to better long-term demand for AMD's server CPUs and now sees revenue at $20.5 billion in 2027, rising to $25 billion in 2028. EPS targets moved higher as well, to $13.40 for 2027 and $18.75 for 2028, sticking with a 33x multiple on 2028 estimates. AMD is ramping up 2-nanometer EPYC Venice chips and aims for broader output in the second half of 2026. The server CPU market could hit $120 billion by 2030. AMD also added to AI infrastructure with the MEXT buy and a cloud bet on TensorWave, backing its artificial intelligence strategy.
Nippon India Silver ETF price today: SILVERBEES slides as silver swings shake bullion ETFs
Previous Story

Nippon India Silver ETF price today: SILVERBEES slides as silver swings shake bullion ETFs

Johnson & Johnson stock rises as new Erleada survival data lands
Next Story

Johnson & Johnson stock rises as new Erleada survival data lands

Go toTop